Works matching IS 2160763X AND DT 2016 AND VI 5
Results: 68
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 427, doi. 10.1002/cpdd.229
- Publication type:
- Article
Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 460, doi. 10.1002/cpdd.254
- By:
- Publication type:
- Article
Impact of Renal Impairment on the Pharmacokinetics of Apremilast and Metabolite M12.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 469, doi. 10.1002/cpdd.256
- By:
- Publication type:
- Article
The Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Japanese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 480, doi. 10.1002/cpdd.259
- By:
- Publication type:
- Article
Glycemic Effect and Safety of a Systemic, Partial Glucokinase Activator, PF-04937319, in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin-A Randomized, Crossover, Active-Controlled Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 517, doi. 10.1002/cpdd.261
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 548, doi. 10.1002/cpdd.262
- By:
- Publication type:
- Article
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals With Renal Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 488, doi. 10.1002/cpdd.263
- By:
- Publication type:
- Article
Electrocardiographic Effects of a Supratherapeutic Dose of Oritavancin.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 502, doi. 10.1002/cpdd.268
- By:
- Publication type:
- Article
Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 509, doi. 10.1002/cpdd.272
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Safety of ASP015K (Peficitinib), a New Janus Kinase Inhibitor, in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 435, doi. 10.1002/cpdd.273
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Piragliatin, a Glucokinase Activator, and Glyburide, a Sulfonylurea, in Type 2 Diabetic Patients.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 552, doi. 10.1002/cpdd.276
- By:
- Publication type:
- Article
Effect of Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, on the QTcF Interval in Humans.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 450, doi. 10.1002/cpdd.278
- By:
- Publication type:
- Article
Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 528, doi. 10.1002/cpdd.290
- By:
- Publication type:
- Article
Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 538, doi. 10.1002/cpdd.291
- By:
- Publication type:
- Article
Clinical Pharmacology in Drug Development: Five Years in the Books.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
2016 Annual Meeting of the American College of Clinical Pharmacology, September 25-27, 2016, Bethesda, MD.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, p. 3, doi. 10.1002/cpdd.292
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, p. 1, doi. 10.1002/cpdd.306
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 327, doi. 10.1002/cpdd.228
- Publication type:
- Article
Effects of Food Intake on the Pharmacokinetics of Azilsartan Medoxomil and Chlorthalidone Alone and in Fixed-Dose Combination in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 393, doi. 10.1002/cpdd.249
- By:
- Publication type:
- Article
In Silico Predictions and In Vivo Results of Drug-Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 364, doi. 10.1002/cpdd.250
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 408, doi. 10.1002/cpdd.251
- By:
- Publication type:
- Article
Effects of Age, Sex, and Obesity on the Single-Dose Pharmacokinetics of Omarigliptin in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 374, doi. 10.1002/cpdd.255
- By:
- Publication type:
- Article
A Thorough QTc Study Confirms Early Pharmacokinetics/QTc Modeling: A Supratherapeutic Dose of Omarigliptin, a Once-Weekly DPP-4 Inhibitor, Does Not Prolong the QTc Interval.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 383, doi. 10.1002/cpdd.260
- By:
- Publication type:
- Article
Single-Dose Pharmacokinetic Study of Tramadol Extended-Release Tablets in Children and Adolescents.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 343, doi. 10.1002/cpdd.266
- By:
- Publication type:
- Article
Confirmation of Biosimilarity in a Pharmacokinetic/Pharmacodynamic Study in Healthy Volunteers for an Analytically Highly Similar Pegfilgrastim.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 354, doi. 10.1002/cpdd.269
- By:
- Publication type:
- Article
Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 336, doi. 10.1002/cpdd.270
- By:
- Publication type:
- Article
Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 399, doi. 10.1002/cpdd.274
- By:
- Publication type:
- Article
Stereo-Psychopharmacology: The Case of Citalopram and Escitalopram.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 331, doi. 10.1002/cpdd.293
- By:
- Publication type:
- Article
A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 259, doi. 10.1002/cpdd.237
- By:
- Publication type:
- Article
Phase IA Clinical Trial Evaluating the Tolerability, Pharmacokinetics, and Analgesic Efficacy of an Intrathecally Administered Neurotensin A Analogue in Central Neuropathic Pain Following Spinal Cord Injury.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 250, doi. 10.1002/cpdd.253
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 241, doi. 10.1002/cpdd.227
- Publication type:
- Article
Phase 1 Study of Safety, Tolerability, and Pharmacokinetics of PTC299, an Inhibitor of Stress-Regulated Protein Translation.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 296, doi. 10.1002/cpdd.240
- By:
- Publication type:
- Article
A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 314, doi. 10.1002/cpdd.241
- By:
- Publication type:
- Article
A Pharmacokinetic Study Comparing Eslicarbazepine Acetate Administered Orally as a Crushed or Intact Tablet in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 278, doi. 10.1002/cpdd.242
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 306, doi. 10.1002/cpdd.244
- By:
- Publication type:
- Article
Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 285, doi. 10.1002/cpdd.245
- By:
- Publication type:
- Article
Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 269, doi. 10.1002/cpdd.246
- By:
- Publication type:
- Article
Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4β-Hydroxycholesterol and Changes in Midazolam Exposure.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 245, doi. 10.1002/cpdd.265
- By:
- Publication type:
- Article
A Phase 1, Randomized, Single-Dose Crossover Pharmacokinetic Study to Investigate the Effect of Food Intake on Absorption of Orteronel (TAK-700) in Healthy Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 188, doi. 10.1002/cpdd.233
- By:
- Publication type:
- Article
Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 180, doi. 10.1002/cpdd.234
- By:
- Publication type:
- Article
Pharmacokinetics of the Long-Acting Basal Insulin LY2605541 in Subjects With Varying Degrees of Renal Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 216, doi. 10.1002/cpdd.252
- By:
- Publication type:
- Article
Sex and Food Influence on Intestinal Absorption of Ketoprofen Gastroresistant Formulation.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 196, doi. 10.1002/cpdd.208
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 163, doi. 10.1002/cpdd.226
- Publication type:
- Article
Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical Studies.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 170, doi. 10.1002/cpdd.243
- By:
- Publication type:
- Article
Meldonium (Mildronate): A Performance-Enhancing Drug?
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Investigation of Drug-Drug Interactions Between Ritobegron, a Selective β<sub>3</sub>-Adrenoceptor Agonist, With Probenecid in Healthy Men.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 201, doi. 10.1002/cpdd.212
- By:
- Publication type:
- Article
Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol- O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 232, doi. 10.1002/cpdd.217
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 225, doi. 10.1002/cpdd.218
- By:
- Publication type:
- Article
Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 3, p. 208, doi. 10.1002/cpdd.219
- By:
- Publication type:
- Article
In Memoriam: David A. Flockhart, 1952-2015.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 2, p. 89, doi. 10.1002/cpdd.258
- By:
- Publication type:
- Article